Personalizable pessary for pelvic organ prolapse
Official title: Evaluation of a Novel Personalizable Pessary for the Treatment of Pelvic Organ Prolapse
Run by University of Alberta · NCT06954701 · Data updated 2026-11-12
A new, custom-fit pessary made with 3D printing will be tested to see if it works as well as standard pessaries for women with pelvic organ prolapse.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 43 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT06954701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with symptomatic pelvic organ prolapse using a pessary for at least 3 months.
✕Probably not a fit
Those who do not experience adequate relief or who have contraindications or intolerance to pessaries may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a novel personalizable pessary designed to match the natural shape of the vagina and be easier to remove and reinsert. It compares the personalizable pessary to standard pessaries in terms of efficacy and safety for treating pelvic organ prolapse. Eligible participants are adults with symptomatic prolapse who have been using a pessary for at least 3 months. The trial aims to determine non-inferiority in symptom relief while monitoring adverse events and device-related issues. Recruitment is centered at the University of Alberta and affiliated centers in Edmonton, Canada.
Why it matters
Potential benefit: If successful, the personalizable pessary could improve fit, comfort, and continuation rates, reducing symptoms and need for surgical intervention.
How similar studies have gone: Previous pessaries have had limited fit and adherence, but 3D-printed, personalized designs are a newer approach with early exploratory evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients assigned female at birth * At least 18 years old at time of screening * Patients with symptomatic POP using a pessary for ≥ 3 months * Capable of giving informed consent * Fluency in English Exclusion Criteria: * Pregnancy * Short vaginal length (total vaginal length \<5 cm) or subjective vaginal narrowing * Vaginal erosion due to current pessary * Presence of vesicovaginal fistula * Presence of rectovaginal fistula * Current treatment for vaginal, rectal, or bladder tumor * Presence of open wound or tear near vagina or anus by exam prior to removal of current pessary * Presence of pelvic, vaginal, or urinary infection requiring treatment * Ongoing treatment of recurrent urinary tract or vaginal infections * Inflammatory bowel disease * Chronic pain syndromes of pelvic or anorectal origin * Previous pelvic floor surgery in last 12 months * Congenital malformation of bladder, rectum, or vagina * Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, ambulatory restrictions, etc.) * Planning pregnancy in next 6 months
Where it's running
-
Dale Sheard Centre for Solutions in Women's Health
Edmonton, Alberta, Canada Recruiting
Study contacts
- Study coordinator: May Sanaee, BSc MD FRCSC MHScEd
- Email: sanaee@ualberta.ca
- Phone: 1-780-735-5290
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk predictor for new urinary incontinence after prolapse surgery
This study tests a model to predict which women might develop new stress urinary incontinence after pelvic organ prolapse repair.
-
Comparing the Manchester procedure versus vaginal hysterectomy for uterine prolapse
This study tests whether the Manchester procedure or vaginal hysterectomy works better for women with symptomatic uterine prolapse over a two-year follow-up.
-
Poly-L-lactic acid injections for vulvovaginal tissue regeneration
This trial will try injections of poly-L-lactic acid (PLLA) versus placebo to see if they strengthen vaginal tissue and reduce bulge symptoms and sexual problems in women with stage II anterior vaginal wall prolapse (cystocele).
-
Pelvic floor mesh used in laparoscopic sacrocolpopexy to repair pelvic organ prolapse
This study tests the ProGYNious mesh to see if it safely and effectively repairs pelvic organ prolapse in adults undergoing laparoscopic surgery.
-
Paracervical block for pain control after vNOTES uterosacral ligament suspension
This will test whether a paracervical injection of bupivacaine reduces early postoperative pain in women having vNOTES uterosacral ligament suspension for pelvic organ prolapse.
-
Postpartum pelvic floor recovery and early rehabilitation after vaginal birth
This project tests whether early, individualized pelvic floor muscle training starting 2–3 weeks after a vaginal birth helps people with postpartum pelvic floor symptoms recover better than usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.